Friday, DUSA Pharmaceuticals Inc. (DUSA) said its third-quarter GAAP net loss narrowed to $0.4 million or $0.02 per share from $2.8 million or $0.12 per share in the prior year period.
Non-GAAP net loss for the quarter, was $0.2 million or $0.01 per share narrower than $1.6 million or $0.07 per common share in the year-ago period.
Product revenues for the quarter rose to $6.93 million from $5.72 million in the comparable period.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.